CYTX stock forecast
Our latest prediction for Cytori Therapeutics, Inc.'s stock price was made on the Feb. 14, 2018 when the stock price was at 3.60$.
In the short term (2weeks), CYTX's stock price should underperform the market by -1.75%. During that period the price should oscillate between -14.03% and +18.93%.
In the medium term (3months), CYTX's stock price should outperform the market by 4.11%. During that period the price should oscillate between -27.49% and +53.28%.Get email alerts
About Cytori Therapeutics, Inc.
Cytori Therapeutics, Inc. is a late stage cell therapy company, which engages in the development of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions. It offers the Cytori Nanomedicine, Cytori Cell Therapy, and other clinical trials. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in San Diego, CA.
At the moment the company generates 7M USD in revenues.
On its last earning announcement, the company reported a loss of -3.83$ per share.
The book value per share is 0.62$
Three months stock forecastFeb. 14, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|